Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 153

1.

A large aperture row column addressed probe for in vivo 4D ultrafast doppler ultrasound imaging.

Sauvage J, Flesch M, Férin G, Nguyen-Dinh A, Porée J, Tanter M, Pernot M, Deffieux T.

Phys Med Biol. 2018 Oct 24;63(21):215012. doi: 10.1088/1361-6560/aae427.

PMID:
30353889
2.

A large aperture row column addressed probe for <i>in vivo</i> 4D ultrafast doppler ultrasound imaging.

Sauvage J, Flesch M, Ferin G, Nguyen-Dinh A, Poree J, Tanter M, Pernot M, Deffieux T.

Phys Med Biol. 2018 Sep 25. doi: 10.1088/1361-6560/aae427. [Epub ahead of print]

PMID:
30251966
3.

4D in vivo ultrafast ultrasound imaging using a row-column addressed matrix and coherently-compounded orthogonal plane waves.

Flesch M, Pernot M, Provost J, Ferin G, Nguyen-Dinh A, Tanter M, Deffieux T.

Phys Med Biol. 2017 Jun 7;62(11):4571-4588. doi: 10.1088/1361-6560/aa63d9. Epub 2017 Mar 1.

PMID:
28248655
4.

[Wine consumption and prevention of coronary artery disease].

Flesch M, Morbach S, Erdmann E, Bulut D.

Herz. 2016 Sep;41(6):469-77. doi: 10.1007/s00059-016-4467-8. German.

PMID:
27541820
5.

FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial.

Hebbar M, Chibaudel B, André T, Mineur L, Smith D, Louvet C, Dutel JL, Ychou M, Legoux JL, Mabro M, Faroux R, Auby D, Brusquant D, Khalil A, Truant S, Hadengue A, Dalban C, Gayet B, Paye F, Pruvot FR, Bonnetain F, Landi B, Flesch M, Carola E, Martin P, Vaillant E, de Gramont A; Group Coopérateur Multidisciplinaire en Oncologie (GERCOR) Group.

Ann Oncol. 2015 Feb;26(2):340-7. doi: 10.1093/annonc/mdu539. Epub 2014 Nov 17. Erratum in: Ann Oncol. 2015 May;26(5):1040. Taieb, J [removed]; Brucker, P [removed].

PMID:
25403578
6.

Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France).

Maynadié M, Girodon F, Manivet-Janoray I, Mounier M, Mugneret F, Bailly F, Favre B, Caillot D, Petrella T, Flesch M, Carli PM.

Haematologica. 2011 Jan;96(1):55-61. doi: 10.3324/haematol.2010.026252. Epub 2010 Oct 22.

7.

Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients.

Etienne-Grimaldi MC, Milano G, Maindrault-Goebel F, Chibaudel B, Formento JL, Francoual M, Lledo G, André T, Mabro M, Mineur L, Flesch M, Carola E, de Gramont A.

Br J Clin Pharmacol. 2010 Jan;69(1):58-66. doi: 10.1111/j.1365-2125.2009.03556.x.

8.

Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study.

Chibaudel B, Maindrault-Goebel F, Lledo G, Mineur L, André T, Bennamoun M, Mabro M, Artru P, Carola E, Flesch M, Dupuis O, Colin P, Larsen AK, Afchain P, Tournigand C, Louvet C, de Gramont A.

J Clin Oncol. 2009 Dec 1;27(34):5727-33. doi: 10.1200/JCO.2009.23.4344. Epub 2009 Sep 28.

PMID:
19786657
9.

FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level: an exploratory cohort of the GERCOR OPTIMOX1 study.

Chibaudel B, Tournigand C, Artru P, André T, Cervantes A, Figer A, Lledo G, Flesch M, Buyse M, Mineur L, Carola E, Rivera F, Perez-Staub N, Louvet C, de Gramont A.

Ann Oncol. 2009 Aug;20(8):1383-6. doi: 10.1093/annonc/mdp012. Epub 2009 May 22.

PMID:
19465426
10.

In-vivo measurements of coronary blood flow using 16-slice multidetector spiral computed tomography (MDCT) in a porcine model.

Krug KB, Bovenschulte H, Geissler HJ, Flesch M, Schneider T, Brackrogge D, Reiter H, Heppelmann I, Christ H, Fischer JH, Lackner KJ.

Rofo. 2009 Mar;181(3):220-9. doi: 10.1055/s-0028-1109054. Epub 2009 Feb 19.

PMID:
19229787
11.

ARTA: AT1-receptor blocker therapy in patients undergoing coronary artery bypass grafting.

Flesch M, Knipp S, Kessler G, Geissler HJ, Massoudy P, Wilhelm H, Philipp T, Erdmann E.

Clin Res Cardiol. 2009 Jan;98(1):33-43. doi: 10.1007/s00392-008-0719-9. Epub 2008 Oct 13.

PMID:
18853093
12.

Implementation of guidelines for the treatment of acute ST-elevation myocardial infarction: the Cologne Infarction Model Registry.

Flesch M, Hagemeister J, Berger HJ, Schiefer A, Schynkowski S, Klein M, Sahebdjami S, vom Dahl S, Fehske W, Mies R, von Eiff M, Pfaff H, Frommolt P, Hoepp HW.

Circ Cardiovasc Interv. 2008 Oct;1(2):95-102. doi: 10.1161/CIRCINTERVENTIONS.108.768176. Epub 2008 Sep 3.

PMID:
20031663
13.

[Severe myocardial infarction due to late and very late stent thrombosis after coronary artery stenting with drug-eluting stents].

Krausgrill B, Erdmann E, Flesch M.

Dtsch Med Wochenschr. 2008 Oct;133(40):2014-7. doi: 10.1055/s-0028-1085610. Epub 2008 Sep 25. German.

PMID:
18819044
14.

Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction.

Müller-Ehmsen J, Braun D, Schneider T, Pfister R, Worm N, Wielckens K, Scheid C, Frommolt P, Flesch M.

Eur Heart J. 2008 Jun;29(12):1560-8. doi: 10.1093/eurheartj/ehn213. Epub 2008 May 30.

PMID:
18515295
15.

FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.

Figer A, Perez-Staub N, Carola E, Tournigand C, Lledo G, Flesch M, Barcelo R, Cervantes A, André T, Colin P, Louvet C, de Gramont A.

Cancer. 2007 Dec 15;110(12):2666-71.

16.

Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.

André T, Quinaux E, Louvet C, Colin P, Gamelin E, Bouche O, Achille E, Piedbois P, Tubiana-Mathieu N, Boutan-Laroze A, Flesch M, Lledo G, Raoul Y, Debrix I, Buyse M, de Gramont A.

J Clin Oncol. 2007 Aug 20;25(24):3732-8.

PMID:
17704423
17.

Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer.

de Gramont A, Buyse M, Abrahantes JC, Burzykowski T, Quinaux E, Cervantes A, Figer A, Lledo G, Flesch M, Mineur L, Carola E, Etienne PL, Rivera F, Chirivella I, Perez-Staub N, Louvet C, André T, Tabah-Fisch I, Tournigand C.

J Clin Oncol. 2007 Aug 1;25(22):3224-9.

PMID:
17664470
18.

The problem of polypharmacy in heart failure.

Flesch M, Erdmann E.

Curr Cardiol Rep. 2006 May;8(3):217-25. Review.

PMID:
17543249
19.

Loss of beta1D-integrin function in human ischemic cardiomyopathy.

Pfister R, Acksteiner C, Baumgarth J, Burst V, Geissler HJ, Margulies KB, Houser S, Bloch W, Flesch M.

Basic Res Cardiol. 2007 May;102(3):257-64. Epub 2006 Dec 29.

PMID:
17186162
20.

Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis.

Molucon-Chabrot C, Isambert N, Benoit L, Zanetta S, Fraisse J, Guilland JC, Royer B, Monin-Baroille P, Flesch M, Fargeot P, Coudert B, Mayer F, Fumoleau P, Chauffert B.

Anticancer Drugs. 2006 Nov;17(10):1211-7.

PMID:
17075321

Supplemental Content

Loading ...
Support Center